MATTERHORN: Efficacy and safety of neoadjuvant-adjuvant durvalumab and FLOT chemotherapy in resectable gastric and gastroesophageal junction cancer-A randomized, double-blind, placebo-controlled, phase 3 study.

被引：21
|
作者：
Janjigian, Yelena Y.
Van Cutsem, Eric
Muro, Kei
Wainberg, Zev A.
Al-Batran, Salah-Eddin
Hyung, Woo Jin
Molena, Daniela
Evans, Brent
Ruscica, Dario
Robbins, Scott H.
Negro, Alejandra
Tabernero, Josep
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Univ Hosp Gasthuisberg, Leuven, Belgium
[3] KU Leuven, Leuven, Belgium
[4] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan
[5] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA USA
[6] Univ Canc Ctr, Frankfurt, Germany
[7] Univ Coll Med, Seoul, South Korea
[8] AstraZeneca, Gaithersburg, MD USA
[9] UVic UCC, Vall dHebron Univ Hosp & Vall dHebron Inst Oncol, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.TPS4151
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4151
引用
收藏
页数：3
相关论文
共 50 条
  • [31] A phase 2/3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rimegepant for the preventive treatment of migraine
    Croop, R.
    Lipton, R. B.
    Kudrow, D.
    Stock, D. A.
    Kamen, L.
    Conway, C. M.
    Stock, E. G.
    Coric, V
    Goadsby, P. J.
    HEADACHE, 2021, 61 : 98 - 99
  • [32] A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety and Efficacy of Romiplostim in Children with Immune Thrombocytopenia (ITP)
    Tarantino, Michael D.
    Bussel, James B.
    Blanchette, Victor S.
    Despotovic, Jenny
    Bennett, Carolyn
    Raj, Ashok
    Williams, Bronwyn
    Beam, Donald
    Morales, Jaime
    Rose, Melissa J.
    Carpenter, Nancy
    Nie, Kun
    Eisen, Melissa
    BLOOD, 2015, 126 (23)
  • [33] Safety and Efficacy of Ataluren in nmDMD Patients from Study 041, a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial
    McDonald, Craig M.
    Wu, Shiwen
    Gulati, Sheffali
    Komaki, Hirofumi
    Escobar, Rosa E.
    Kostera-Pruszczyk, Anna
    Vlodavets, Dmitry
    Chae, Jong-Hee
    Jong, Yuh-Jyh
    Karachunski, Peter
    Statland, Jeffrey
    Lorentzos, Michelle
    Penematsa, Vinay
    Chou, Connie
    Lin, Min
    Werner, Christian
    Trifillis, Panayiota
    Gordon, Gregory
    Koladicz, Karyn
    Mastrandrea, Nicholas
    Klein, Matthew
    NEUROLOGY, 2023, 100 (17)
  • [34] A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant for the Preventive Treatment of Migraine
    Croop, Robert
    Lipton, Richard
    Thiry, Alexandra
    Kamen, Lisa
    Coric, Vlad
    Goadsby, Peter
    NEUROLOGY, 2021, 96 (15)
  • [35] Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension: phase 3 randomized, double-blind placebo-controlled study
    Ivy, Dunbar
    Bonnet, Damien
    Berger, Rolf
    Meyer, Gisela M. B.
    Baygani, Simin
    Li, Baohui
    PULMONARY CIRCULATION, 2021, 11 (03)
  • [36] The Efficacy and Safety of Piclidenoson vs Methotrexate in Early Rheumatoid Arthritis: Phase 3 Randomized, Double-blind, Placebo-controlled Study
    Reitblat, Tatiana
    Gurman-Balbir, Alexandra
    Harpaz, Zivit
    Farbstein, Motti
    Silverman, Michael
    Kerns, William
    Fishman, Pnina
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3564 - 3566
  • [37] A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis
    Schmidt, Wolfgang A.
    Dasgupta, Bhaskar
    Sloane, Jennifer
    Giannelou, Angeliki
    Xu, Yuqing
    Unizony, Sebastian H.
    Mackie, Sarah L.
    Gonzalez-Gay, Miguel A.
    Spiera, Robert
    Warrington, Kenneth J.
    Villiger, Peter M.
    Nivens, Michael C.
    Akinlade, Bolanle
    Lin, Yong
    Buttgereit, Frank
    Stone, John H.
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [38] A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis
    Wolfgang A. Schmidt
    Bhaskar Dasgupta
    Jennifer Sloane
    Angeliki Giannelou
    Yuqing Xu
    Sebastian H. Unizony
    Sarah L. Mackie
    Miguel A. Gonzalez-Gay
    Robert Spiera
    Kenneth J. Warrington
    Peter M. Villiger
    Michael C. Nivens
    Bolanle Akinlade
    Yong Lin
    Frank Buttgereit
    John H. Stone
    Arthritis Research & Therapy, 25
  • [39] A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant for the Preventive Treatment of Migraine
    Croop, R.
    Lipton, R. B.
    Kudrow, D.
    Stock, D. A.
    Kamen, L.
    Conway, C. M.
    Stock, E. G.
    Coric, V.
    Goadsby, P. J.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 19 - 19
  • [40] Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial
    Zhao, Ying
    Yang, Yuan-Yuan
    Yang, Bao-Lin
    Du, Ya-Wei
    Ren, Da-Wei
    Zhou, Hong-Mei
    Wang, Jing
    Yang, Hui-Min
    Wang, Yao-Xian
    Zhang, Ying-Ying
    Wu, Sheng-Xian
    TRIALS, 2021, 22 (01)
12345